| 1 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
| 2 |
Advate |
- |
- |
- |
- |
288 [1] 288 💬 |
| 3 |
Advate (rahf - pfm) |
Antihemophilic factor, human recombinant |
[1] D02958 D02958 💬 |
- |
- |
288 [1] 288 💬 |
| 4 |
Advate (rahf-pfm) |
Antihemophilic factor, human recombinant |
[1] D02958 D02958 💬 |
- |
- |
288 [1] 288 💬 |
| 5 |
Advate 1000 iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
| 6 |
Advate 1000iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
| 7 |
Advate 500 iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
| 8 |
Alphanate |
- |
- |
- |
- |
288 [1] 288 💬 |
| 9 |
Alphanate 1000 i.u. |
- |
- |
- |
- |
288 [1] 288 💬 |
| 10 |
Alphanate 1500 i.u. |
- |
- |
- |
- |
288 [1] 288 💬 |
| 11 |
Alphanate sd/ht |
- |
- |
- |
- |
288 [1] 288 💬 |
| 12 |
Alphanate*inf 1f 1000ui+f 10ml |
- |
- |
- |
- |
288 [1] 288 💬 |
| 13 |
Alphanate*inf 1f 1500ui+f 10ml |
- |
- |
- |
- |
288 [1] 288 💬 |
| 14 |
Alphanate*inf 1f 250ui+f 5ml |
- |
- |
- |
- |
288 [1] 288 💬 |
| 15 |
Alphanate*inf 1f 500ui+f 5ml |
- |
- |
- |
- |
288 [1] 288 💬 |
| 16 |
Antihemophilic factor (recombinant) |
- |
- |
- |
- |
288 [1] 288 💬 |
| 17 |
Apcc, apcc + txa |
- |
- |
- |
- |
288 [1] 288 💬 |
| 18 |
Arc 1779 |
- |
- |
- |
- |
064 [2] 64, 288 💬 |
| 19 |
Arc1779 |
- |
- |
- |
- |
064 [2] 64, 288 💬 |
| 20 |
Arc1779 injection |
- |
- |
- |
- |
064 [2] 64, 288 💬 |
| 21 |
Bax 111 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 22 |
Bax111 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 23 |
Biostate |
- |
- |
- |
- |
288 [1] 288 💬 |
| 24 |
Biostate® |
- |
- |
- |
- |
288 [1] 288 💬 |
| 25 |
Bivv001 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 26 |
Bivv001 (rfviiifc-vwf-xten) |
- |
- |
- |
- |
288 [1] 288 💬 |
| 27 |
Blood coagulation factor viii and vwf, human |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 28 |
Blood sample |
- |
- |
- |
- |
008 [13] 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
| 29 |
Bortezomib |
Bortezomib |
[1] D03150 D03150 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
| 30 |
Catridecacog |
Catridecacog |
[1] D10532 D10532 💬 |
- |
- |
097 [2] 97, 288 💬 |
| 31 |
Chloride |
Chloride ion |
- |
- |
- |
006 [25] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
| 32 |
Cluvot |
- |
- |
- |
- |
288 [1] 288 💬 |
| 33 |
Coagulación factor viii |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 34 |
Coagulation factor viii |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 35 |
Coagulation factor xiii |
Factor XIII (human) |
- |
- |
- |
288 [1] 288 💬 |
| 36 |
Cofactor |
- |
- |
- |
- |
006 [3] 6 , 265, 288 💬 |
| 37 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
| 38 |
Ddavp |
Desmopressin |
[2] D00291 D00291, D02235 D02235 💬 |
AVPR2 [2] AVPR2, F8 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
075 [2] 75, 288 💬 |
| 39 |
Ddavp (desmopressin) |
Desmopressin |
[2] D00291 D00291, D02235 D02235 💬 |
AVPR2 [2] AVPR2, F8 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
288 [1] 288 💬 |
| 40 |
Desmopressin |
Desmopressin |
[2] D00291 D00291, D02235 D02235 💬 |
AVPR2 [2] AVPR2, F8 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
006 [5] 6 , 64, 72, 225, 288 💬 |
| 41 |
Desmopressin acetate |
Acetate |
[2] D00291 D00291, D02235 D02235 💬 |
AVPR2 [2] AVPR2, F8 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
064 [2] 64, 288 💬 |
| 42 |
Desmopressine |
Desmopressin |
[2] D00291 D00291, D02235 D02235 💬 |
AVPR2 [2] AVPR2, F8 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
225 [2] 225, 288 💬 |
| 43 |
Device: sublingual videomicroscopy |
- |
- |
- |
- |
288 [1] 288 💬 |
| 44 |
Diagnostic test: blood sample , doppler of uterine vessel and placenta |
- |
- |
- |
- |
288 [1] 288 💬 |
| 45 |
Diagnostic test: fibrinogen plasma concentration, coagulation factor xiii activity |
Factor XIII (human) |
- |
- |
- |
288 [1] 288 💬 |
| 46 |
Emicizumab |
Emicizumab |
[1] D10821 D10821 💬 |
F10 [2] F10, F9 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
288 [1] 288 💬 |
| 47 |
Emicizumab (ace910, ro5534262) |
Emicizumab |
[1] D10821 D10821 💬 |
F10 [2] F10, F9 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
288 [1] 288 💬 |
| 48 |
Emicizumab injection |
Emicizumab |
[1] D10821 D10821 💬 |
F10 [2] F10, F9 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
288 [1] 288 💬 |
| 49 |
Eqwilate |
- |
- |
- |
- |
288 [1] 288 💬 |
| 50 |
F13cd |
- |
- |
- |
- |
288 [1] 288 💬 |
| 51 |
F8vr |
- |
- |
- |
- |
288 [1] 288 💬 |
| 52 |
Factane 200 iu/ml |
- |
- |
- |
- |
288 [1] 288 💬 |
| 53 |
Factor viii |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 54 |
Factor viii concentrate |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 55 |
Factor von willebrand |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 56 |
Factor xiii |
Factor XIII (human) |
- |
- |
- |
051 [3] 51, 97, 288 💬 |
| 57 |
Factor xiii concentrate (human) |
Factor XIII (human) |
- |
- |
- |
288 [1] 288 💬 |
| 58 |
Factor xiii concentrate (human), pasteurized |
Factor XIII (human) |
- |
- |
- |
288 [1] 288 💬 |
| 59 |
Fanhdi |
- |
- |
- |
- |
288 [1] 288 💬 |
| 60 |
Fanhdi 100 ui |
- |
- |
- |
- |
288 [1] 288 💬 |
| 61 |
Fanhdi 100 ui fviii-120 ui fvw |
- |
- |
- |
- |
288 [1] 288 💬 |
| 62 |
Fanhdi 25 ui |
- |
- |
- |
- |
288 [1] 288 💬 |
| 63 |
Fanhdi 25 ui fviii-30 ui fvw |
- |
- |
- |
- |
288 [1] 288 💬 |
| 64 |
Fanhdi 250ui*1f 250ui+f 10ml |
- |
- |
- |
- |
288 [1] 288 💬 |
| 65 |
Fanhdi 50 ui |
- |
- |
- |
- |
288 [1] 288 💬 |
| 66 |
Fanhdi 50 ui fviii-60 ui fvw |
- |
- |
- |
- |
288 [1] 288 💬 |
| 67 |
Fanhdi*inf fl 250ui+sir solv+s |
- |
- |
- |
- |
288 [1] 288 💬 |
| 68 |
Fanhdi*inf fl 500ui+sir solv+s |
- |
- |
- |
- |
288 [1] 288 💬 |
| 69 |
Fanhdi*inf fl1000ui+sir solv+s |
- |
- |
- |
- |
288 [1] 288 💬 |
| 70 |
Fanhdi*inf fl250ui+sir solv+s |
- |
- |
- |
- |
288 [1] 288 💬 |
| 71 |
Fibrinogen |
Fibrinogen human |
- |
- |
- |
014 [3] 14, 65, 288 💬 |
| 72 |
Fibrogammin p |
- |
- |
- |
- |
288 [1] 288 💬 |
| 73 |
Fibrogammin® p |
- |
- |
- |
- |
288 [1] 288 💬 |
| 74 |
Fibrogammin®p |
- |
- |
- |
- |
288 [1] 288 💬 |
| 75 |
Fxiii concentrate (human) |
- |
- |
- |
- |
288 [1] 288 💬 |
| 76 |
Fxiii concentrate (human) (fxiii) |
- |
- |
- |
- |
288 [1] 288 💬 |
| 77 |
Haemate p |
- |
- |
- |
- |
288 [1] 288 💬 |
| 78 |
Haemate p® (human coagulation factor viii) |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
| 79 |
Haemate-p, wilate |
- |
- |
- |
- |
288 [1] 288 💬 |
| 80 |
Haemate® p 250 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 81 |
Hemofix |
- |
- |
- |
- |
288 [1] 288 💬 |
| 82 |
Human coagulation factor viii |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
| 83 |
Human coagulation factor viii / von willebrand factor |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
| 84 |
Human coagulation factor viii associated with von willebrand factor (vwf) |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
| 85 |
Human coagulation factor viii, von willebrand factor complex |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
| 86 |
Human von willebrand factor |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 87 |
Human von willebrand factor (vwf) and coagulation factor viii (fviii) |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 88 |
Human vwf/fviii concentrate |
- |
- |
- |
- |
288 [1] 288 💬 |
| 89 |
Humate-p |
- |
- |
- |
- |
288 [1] 288 💬 |
| 90 |
Il-11 |
Oprelvekin |
[1] D05266 D05266 💬 |
IL11RA [1] IL11RA 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
288 [1] 288 💬 |
| 91 |
Interleukin 11 |
Oprelvekin |
[1] D05266 D05266 💬 |
IL11RA [1] IL11RA 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
288 [1] 288 💬 |
| 92 |
Interleukin-11 |
Oprelvekin |
[1] D05266 D05266 💬 |
IL11RA [1] IL11RA 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
096 [2] 96, 288 💬 |
| 93 |
Marketed plasma-derived vwf/fviii concentrate |
- |
- |
- |
- |
288 [1] 288 💬 |
| 94 |
Minirin |
- |
- |
- |
- |
064 [2] 64, 288 💬 |
| 95 |
Minrin |
- |
- |
- |
- |
288 [1] 288 💬 |
| 96 |
Natriumchlorid |
Sodium chloride |
[1] D02056 D02056 💬 |
- |
- |
288 [1] 288 💬 |
| 97 |
Natriumchlorid 0,9 % |
Sodium chloride |
[1] D02056 D02056 💬 |
- |
- |
288 [1] 288 💬 |
| 98 |
Neumega (oprelvekin, interleukin 11, il-11) |
Oprelvekin |
[1] D05266 D05266 💬 |
IL11RA [1] IL11RA 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
288 [1] 288 💬 |
| 99 |
Nn 1841 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 100 |
Nn1841 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 101 |
Obi-1 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 102 |
Obizur |
- |
- |
- |
- |
288 [1] 288 💬 |
| 103 |
Obyoctocog alfa |
- |
- |
- |
- |
288 [1] 288 💬 |
| 104 |
Octanate |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 105 |
Octanate 100 ui/ml, poudre et solvant pour solution injectable |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 106 |
Octanate 50 ui/ml, poudre et solvant pour solution injectable |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 107 |
Octocog alfa |
Antihemophilic factor, human recombinant |
[1] D02958 D02958 💬 |
- |
- |
288 [1] 288 💬 |
| 108 |
Octostim |
- |
- |
- |
- |
064 [2] 64, 288 💬 |
| 109 |
Oprelvekin |
Oprelvekin |
[1] D05266 D05266 💬 |
IL11RA [1] IL11RA 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
288 [1] 288 💬 |
| 110 |
Oprelvekin, interleukin 11, il-11 |
Oprelvekin |
[1] D05266 D05266 💬 |
IL11RA [1] IL11RA 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
288 [1] 288 💬 |
| 111 |
Optivate |
- |
- |
- |
- |
288 [1] 288 💬 |
| 112 |
Optivate® (human coagulation factor viii) |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
| 113 |
Other: use of a postpartum diary and additional blood draws |
- |
- |
- |
- |
288 [1] 288 💬 |
| 114 |
Other: use of a postpartum diary and additional blood draws. |
- |
- |
- |
- |
288 [1] 288 💬 |
| 115 |
Physiologische kochsalzlösung fresenius - infusionslösung |
- |
- |
- |
- |
288 [1] 288 💬 |
| 116 |
Phytomenadione |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
288 [1] 288 💬 |
| 117 |
Plasma-derived fviii/vwf concentrate |
- |
- |
- |
- |
288 [1] 288 💬 |
| 118 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
| 119 |
Prothrombin |
Prothrombin |
- |
- |
- |
288 [1] 288 💬 |
| 120 |
Prothrombin complex concentrate |
Factor IX Complex (Human) |
- |
- |
- |
288 [1] 288 💬 |
| 121 |
Rahf |
Antihemophilic factor, human recombinant |
[1] D02958 D02958 💬 |
- |
- |
288 [1] 288 💬 |
| 122 |
Recombinant coagulation fviii fc – von willebrand factor – xten fusion protein |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 123 |
Recombinant coagulation fviii fc – vonwillebrand factor – xten fusion protein |
- |
- |
- |
- |
288 [1] 288 💬 |
| 124 |
Recombinant factor viiii (rfviii) |
- |
- |
- |
- |
288 [1] 288 💬 |
| 125 |
Recombinant factor xiii |
Factor XIII (human) |
- |
- |
- |
288 [1] 288 💬 |
| 126 |
Recombinant factor xiii (rfxiii) |
Factor XIII (human) |
- |
- |
- |
097 [2] 97, 288 💬 |
| 127 |
Recombinant human coagulation factor viii fc - von willebrand factor - xten fusion protein |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
| 128 |
Recombinant human von willebrand factor |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 129 |
Recombinant interleukin-11 |
Oprelvekin |
[1] D05266 D05266 💬 |
IL11RA [1] IL11RA 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
288 [1] 288 💬 |
| 130 |
Recombinant porcine coagulation factor viii (b domain deleted) |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 131 |
Recombinant porcine coagulation factor viii (b-domain deleted) |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 132 |
Recombinant von willebrand factor |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 133 |
Recombinant von willebrand factor (rvwf) |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 134 |
Recombinant von willebrand factor 1300iu |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 135 |
Recombinant von willebrand factor 650iu |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 136 |
Recombinant von willebrand factor : recombinant fviii (rvwf:rfviii) |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 137 |
Recomibnant human von willebrand factor |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 138 |
Rfviia |
Coagulation factor VIIa Recombinant Human |
[1] D00172 D00172 💬 |
- |
- |
288 [1] 288 💬 |
| 139 |
Rfviia, rfviia + txa |
Coagulation factor VIIa Recombinant Human |
[1] D00172 D00172 💬 |
- |
- |
288 [1] 288 💬 |
| 140 |
Rfviii |
- |
- |
- |
- |
288 [1] 288 💬 |
| 141 |
Rituxan |
- |
- |
- |
- |
046 [4] 46, 60, 256, 288 💬 |
| 142 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
| 143 |
Rurioctocog alfa pegol |
Rurioctocog alfa pegol |
[1] D10760 D10760 💬 |
- |
- |
288 [1] 288 💬 |
| 144 |
Rvwf |
- |
- |
- |
- |
288 [1] 288 💬 |
| 145 |
Saline solution |
- |
- |
- |
- |
002 [4] 2 , 34, 288, 299 💬 |
| 146 |
Simvastatin |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
| 147 |
Simvastatine |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [3] 6 , 13, 288 💬 |
| 148 |
Sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [20] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
| 149 |
Sodium chloride solution 0.9% |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
060 [3] 60, 288, 299 💬 |
| 150 |
Standard of care for haemophilia a |
- |
- |
- |
- |
288 [1] 288 💬 |
| 151 |
Standard of care fviii replacement therapy |
- |
- |
- |
- |
288 [1] 288 💬 |
| 152 |
Steroid |
- |
- |
- |
- |
288 [1] 288 💬 |
| 153 |
Tak-672 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 154 |
Tranexamic acid |
Tranexamic acid |
[1] D01136 D01136 💬 |
PLG [1] PLG 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
046 [5] 46, 70, 215, 227, 288 💬 |
| 155 |
Tranexamic acid injection [cyklokapron] |
Tranexamic acid |
[1] D01136 D01136 💬 |
PLG [1] PLG 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
288 [1] 288 💬 |
| 156 |
Uterine |
- |
- |
- |
- |
118 [2] 118, 288 💬 |
| 157 |
Vessel |
- |
- |
- |
- |
013 [4] 13, 51, 271, 288 💬 |
| 158 |
Veyondi 650iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
| 159 |
Veyvondi 1300iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
| 160 |
Veyvondi 650iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
| 161 |
Von willebrand factor |
Von Willebrand Factor Human |
- |
- |
- |
064 [2] 64, 288 💬 |
| 162 |
Von willebrand factor (recombinant) |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 163 |
Von willebrand factor and coagulation factor viii in combination |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 164 |
Von willebrand factor antigen |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 165 |
Von willebrand factor ristocetin cofactor |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 166 |
Von willebrand faktor |
- |
- |
- |
- |
288 [1] 288 💬 |
| 167 |
Voncento |
- |
- |
- |
- |
288 [1] 288 💬 |
| 168 |
Voncento, biostate® |
- |
- |
- |
- |
288 [1] 288 💬 |
| 169 |
Voncento® |
- |
- |
- |
- |
288 [1] 288 💬 |
| 170 |
Vonicog alfa |
Vonicog Alfa |
[1] D08681 D08681 💬 |
- |
- |
288 [1] 288 💬 |
| 171 |
Vwd factor viii concentrate |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 172 |
Vwf replacement therapy with wilate |
- |
- |
- |
- |
288 [1] 288 💬 |
| 173 |
Vwf sd-35-dh |
- |
- |
- |
- |
288 [1] 288 💬 |
| 174 |
Vwf-containing products |
- |
- |
- |
- |
288 [1] 288 💬 |
| 175 |
Vwf/fviii products |
- |
- |
- |
- |
288 [1] 288 💬 |
| 176 |
Wilate |
- |
- |
- |
- |
288 [1] 288 💬 |
| 177 |
Wilate 1000 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 178 |
Wilate 1000 i.u. |
- |
- |
- |
- |
288 [1] 288 💬 |
| 179 |
Wilate 450 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 180 |
Wilate 500 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 181 |
Wilate 500 i.u. |
- |
- |
- |
- |
288 [1] 288 💬 |
| 182 |
Wilate 900 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 183 |
Wilate® 450 |
- |
- |
- |
- |
288 [1] 288 💬 |
| 184 |
Wilfactin |
- |
- |
- |
- |
288 [1] 288 💬 |
| 185 |
Willfact |
- |
- |
- |
- |
288 [1] 288 💬 |
| 186 |
Wiloctin |
- |
- |
- |
- |
288 [1] 288 💬 |